Arcutis Biotherapeutics Inc (ARQT)
15.75
+1.04
(+7.07%)
USD |
NASDAQ |
Jan 07, 16:00
15.76
+0.01
(+0.06%)
After-Hours: 16:14
Arcutis Biotherapeutics Research and Development Expense (Annual): 110.58M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Vertex Pharmaceuticals Inc | 3.69B |
Chimerix Inc | 68.79M |
CytomX Therapeutics Inc | 77.68M |
Spero Therapeutics Inc | 51.44M |
Kodiak Sciences Inc | 206.30M |